Who Qualifies for a Depo Provera Shot Lawsuit? [2026 Guide]

Women who developed a brain or spinal tumor after long-term use of Depo-Provera have filed claims as part of ongoing Depo-Provera litigation against the drug’s manufacturer.

Depo shot lawsuits generally allege that the injectable contraceptive carried under-disclosed health risks, particularly when used over extended periods.

The claims focus on whether adequate warnings were provided about potential neurological outcomes associated with prolonged exposure to depot medroxyprogesterone acetate, a synthetic form of the hormone progesterone used in the injectable birth control drug.

Plaintiffs argue that available scientific data should have prompted clearer risk communication to prescribing providers and patients.

Because many lawsuits raise overlapping factual and scientific questions, federal courts have consolidated these cases into a multidistrict litigation (MDL).

This structure allows coordinated handling of discovery and pretrial issues while preserving each plaintiff’s individual claim. Importantly, the Depo-Provera cases are not a class action, and outcomes depend on the facts of each person’s medical history and diagnosis.

Individuals considering whether they may qualify for a claim typically undergo a review of their Depo-Provera use, diagnostic records, and treatment history.

Lawyers handling Depo-Provera lawsuits evaluate whether those facts align with the allegations currently being addressed in the MDL, including the duration of exposure and the nature of the tumor diagnosed.

Claims are being evaluated on an individual basis as the MDL addresses shared legal and scientific questions central to the cases.

Who Exactly May Qualify for the Depo-Provera Lawsuit?

Individuals who used Depo-Provera and subsequently developed intracranial meningiomas or other serious health complications may qualify for a lawsuit.

Eligibility often depends on proving a link between prolonged use of the contraceptive and the development of the brain tumor, supported by medical and prescription records.

A qualified attorney from TorHoerman Law can review your case and determine if you meet the criteria to file a claim.

Those who may qualify to sue Depo-Provera manufacturer Pfizer include:

• Women diagnosed with intracranial meningiomas after using Depo-Provera.
• Individuals who used Depo-Provera for 12 months or longer.
• Patients whose medical records show a link between Depo-Provera use and brain tumor development.

What is the Depo-Provera Lawsuit Statute of Limitations?

The statute of limitations for filing a Depo-Provera Lawsuit depends on the state where the claim is filed, with most states requiring lawsuits to be initiated within 2 to 3 years of discovering the injury.

This time frame typically begins when a person is diagnosed with a brain tumor or when they reasonably link their condition to Depo-Provera use.

Some states allow exceptions that extend the statute if the harm was not immediately evident or if the plaintiff was unaware of the connection.

Missing the statute of limitations can bar individuals from pursuing legal action, regardless of the severity of their injuries.

Consulting an experienced attorney promptly ensures your claim is filed within the required timeframe and protects your right to seek compensation.

What is the Average Depo-Provera Settlement Amount?

Lawyers estimate that individual Depo-Provera Lawsuit settlement amounts could range between $100,000 and $500,000 or more, depending on individual circumstances.

Factors that could influence the settlement value include the severity of the tumor, the impact on the plaintiff’s quality of life, the cost of medical treatment, and whether the individual has suffered long-term or permanent damage

Additionally, lost wages due to an inability to work and the emotional distress caused by the diagnosis may also play a role in determining the compensation amount.

Please be advised that any projected or estimated settlement amounts mentioned on this page are general estimations and are not guaranteed. These figures are based on similar previous litigations, the nature of injuries sustained, and estimated costs of damages. They are meant to provide a general idea of what settlement ranges could look like and should not be taken as definitive expectations for your case.

Every legal case is unique, with its own specific circumstances that can significantly affect the outcome. This information is not legal advice and does not address the specifics of your situation. To obtain a more accurate understanding of the potential value of your case, it is best to consult directly with a qualified attorney who can provide personalized guidance.

New scientific studies have linked the injectable birth control shot Depo-Provera to an increased risk of developing brain tumors.

In 2024, a study published in the British Medical Journal (BMJ) found that prolonged Depo-Provera use was linked to a 5.6x increased risk of developing intracranial meningioma, a type of brain tumor that arises in the protective membranes surrounding the brain and spinal cord.

Researchers suggest that the hormone progestin, a key ingredient in Depo-Provera, may stimulate abnormal cell growth in these tissues, especially with long-term exposure.

While meningiomas are typically benign, their growth can cause debilitating symptoms, such as seizures, vision loss, and cognitive impairments, depending on their size and location.

Many patients require surgical intervention to remove the tumors, and some may need follow-up radiation treatment or ongoing care to manage symptoms.

The findings have sparked significant concern, as Depo-Provera remains a widely used contraceptive option for millions of women worldwide.

Findings from the BMJ study:

• 5.6x Increased Risk: Women who used Depo-Provera for over a year had a 5.6 times higher risk of developing intracranial meningiomas.
• Progestin’s Role: The synthetic hormone in Depo-Provera, medroxyprogesterone acetate, is believed to stimulate tumor growth in brain tissues.
• Severity of Symptoms: Patients experienced severe neurological symptoms, including seizures, vision loss, and cognitive decline.
• Surgical Interventions: Many cases required brain surgery due to the tumor’s size or impact on nearby brain tissue.

How Do Depo-Provera Contraceptive Injections Cause Brain Tumors?

Depo-Provera contraceptive injections are believed to contribute to brain tumor development through the effects of their active ingredient, medroxyprogesterone acetate, a synthetic form of the hormone progestin.

Prolonged exposure to this hormone can stimulate abnormal growth in the meninges, the protective layers surrounding the brain and spinal cord.

Research has shown that long-term use of Depo-Provera, particularly for over a year, significantly increases the risk of developing intracranial meningiomas.

These tumors may form due to hormonal imbalances created by continuous high levels of progestin in the body, which can alter cellular behavior in brain tissues.

Intracranial meningiomas are a type of brain tumor that arises from the meninges, the protective membranes covering the brain and spinal cord.

These tumors are the most common form of primary brain tumors, accounting for approximately 30-40% of all cases.

Meningiomas are typically classified as benign (Grade I), atypical (Grade II), or malignant (Grade III), with benign tumors being the most common but still capable of causing significant health complications.

Risk factors for developing meningiomas include prolonged hormone exposure, genetic mutations, and prior radiation to the head or neck.

Scientific literature highlights that hormones like progestin, found in some contraceptives, may play a role in tumor growth, making prolonged use of such medications a potential risk.

Symptoms of Intracranial Meningioma

Symptoms of these brain tumors vary depending on the tumor’s size and location but can include persistent headaches, vision problems, seizures, and cognitive impairments.

As the tumor grows, it may place pressure on nearby brain structures, intensifying symptoms over time. Additional signs can include motor weakness, personality changes, and difficulty with coordination or balance.

Early symptoms are often subtle and may be mistaken for other conditions, delaying diagnosis and treatment.

Recognizing these symptoms and seeking medical evaluation is critical for timely intervention, as untreated tumors can lead to permanent neurological damage.

Common Symptoms of Intracranial Meningiomas:

• Persistent headaches that worsen over time.
• Vision problems, including blurred or double vision.
• Seizures or unexplained loss of consciousness.
• Cognitive issues, such as memory loss or confusion.
• Weakness or numbness in the arms or legs.
• Difficulty with balance or coordination.
• Personality or mood changes, including irritability or depression.
• Speech difficulties, such as slurred words or trouble finding the right words.

Diagnostic tools such as MRI and CT scans are essential for identifying these tumors and assessing their impact on surrounding brain structures.

Treatment Options for Intracranial Meningioma Brain Tumors

Treatment options range from monitoring smaller, asymptomatic tumors to surgical removal and radiation therapy for larger or more aggressive growths, with outcomes heavily dependent on early detection and intervention.

Observation, often called “watchful waiting,” may be recommended for slow-growing tumors that are not causing symptoms.

For symptomatic or larger tumors, surgical removal is often the first-line treatment, aiming to excise as much of the tumor as possible without damaging surrounding brain tissue.

Radiation therapy, including stereotactic radiosurgery, may be used to target residual tumor cells or as a primary treatment for inoperable tumors.

Advances in medical technology, such as precision-guided imaging, have improved treatment outcomes and reduced risks associated with surgery.

Recovery plans often include rehabilitation to address neurological deficits and improve quality of life.

The choice of treatment depends on the tumor’s size, location, grade, and the patient’s overall health, underscoring the importance of personalized care.

Long-term monitoring is critical, as meningiomas can recur even after treatment.

Common Treatment Options for Intracranial Meningiomas:

• Observation: Regular imaging to monitor small, asymptomatic tumors.
• Surgical Removal: Complete or partial excision, depending on the tumor’s location.
• Radiation Therapy: Techniques like stereotactic radiosurgery to target remaining tumor cells or treat inoperable tumors.
• Chemotherapy: Rarely used but may be an option for malignant or recurrent tumors.
• Rehabilitation: Physical, occupational, or speech therapy to recover lost function.
• Medication: To manage symptoms such as seizures or swelling caused by the tumor.
• Long-Term Monitoring: Ongoing imaging and evaluations to detect recurrence.

Brain tumors linked to Depo-Provera can deeply affect patients, causing debilitating symptoms like seizures, vision loss, and cognitive impairments that disrupt daily life.

Long-term complications, including permanent neurological damage and the need for ongoing medical care, place significant physical, emotional, and financial burdens on individuals and their families.

Pharmaceutical companies have a responsibility to warn patients and healthcare providers about these serious risks.

When these major drug companies fail to warn of adverse effects, they may be liable in personal injury or product liability lawsuits.

Our law firm is currently investigating the Depo-Provera Lawsuits, representing individuals who have developed brain tumors after using Depo-Provera.

If you or a loved one has developed a brain tumor after Depo-Provera usage, you may be eligible to file a Depo-Provera Lawsuit and seek compensation.

Use the chat feature on this page to find out if you qualify to join others filing Depo-Provera Brain Tumor Lawsuits.

Your lawyer will help you through the entire legal process, gathering and retaining crucial evidence and assessing the full spectrum of damages incurred as a result of the brain tumor diagnosis.

Evidence in Depo-Provera Brain Tumor Lawsuits

Strong evidence is essential in a Depo-Provera Brain Tumor Lawsuit to establish the link between the drug and the development of intracranial meningiomas.

This documentation not only supports claims of negligence against the manufacturer but also demonstrates the full extent of the plaintiff’s injuries and financial losses.

A well-prepared evidence portfolio can strengthen your case and improve the likelihood of securing fair compensation.

Your lawyers will help you gather and retain evidence crucial to your Depo-Provera case.

Potential Evidence in Depo-Provera Brain Tumor Lawsuits include:

• Medical Records: Diagnosis reports, imaging scans, and treatment history related to brain tumors.
• Prescription Records: Proof of Depo-Provera use, including dates, dosages, and refill history.
• Doctor’s Notes and Expert Testimony: Statements linking the tumor to Depo-Provera use.
• Product Information: Copies of drug labels, patient information leaflets, and warnings provided by the manufacturer.
• Personal Health Records: Documentation of symptoms and their progression over time.
• Financial Records: Evidence of lost wages, medical expenses, and other costs stemming from the illness.

Possible Damages in Depo-Provera Meningioma Lawsuits

Damages in a lawsuit refer to the monetary compensation sought by plaintiffs to address the losses they have suffered due to another party’s negligence.

In Depo-Provera Lawsuits, damages are meant to compensate individuals for the physical, emotional, and financial hardships caused by brain tumors linked to the drug.

These damages aim to cover both tangible costs, such as medical bills, and intangible losses, such as pain and suffering.

Accurate calculation of damages is critical to ensure plaintiffs receive fair compensation for their injuries and long-term needs.

Possible Damages in Depo-Provera Meningioma Lawsuits include:

• Medical Expenses: Costs for surgeries, treatments, hospital stays, medications, and follow-up care.
• Lost Wages: Compensation for income lost during recovery and reduced earning capacity.
• Pain and Suffering: Damages for physical pain and emotional distress caused by the illness and its treatment.
• Loss of Quality of Life: Compensation for reduced ability to enjoy daily activities or relationships.
• Future Medical Costs: Projected expenses for long-term care, rehabilitation, or ongoing therapies.
• Permanent Disability: Compensation for lasting impairments or disabilities resulting from the tumor or its treatment.

Recent studies have shown that prolonged use of Depo-Provera may significantly increase the risk of developing intracranial meningiomas, a type of brain tumor.

These findings have prompted women to file lawsuits, alleging that Pfizer failed to provide adequate warnings about the potential risks associated with their contraceptive product.

If you or someone you love has been affected by serious side effects from Depo-Provera, reach out today for a free consultation.

Our team is available to discuss your situation.

You can also get immediate assistance through the chatbot on this page.